John W. Loughney
Papers
3
Total Citations
21
H-Index
3
About
John W. Loughney is a leading researcher in analytical biotechnology, specializing in high-throughput automation for vaccine development and biopharmaceutical quality control. His work centers on creating robust, automated assay platforms to accelerate drug discovery and ensure product safety. A standout contribution is his development of an open-sourced, inexpensive robotic liquid handler for biochemical assays, a breakthrough that democratizes high-throughput screening and has already garnered 11 citations. Loughney further advanced mRNA vaccine safety by developing an automated sandwich ELISA to quantitate residual double-stranded RNA (dsRNA) impurities—a critical impurity in mRNA manufacturing that can impact potency and safety (6 citations). His expertise extends to virology, where he designed a fully automated high-throughput immuno-µPlaque assay for live-attenuated tetravalent dengue vaccines, addressing a global health threat affecting half the world’s population (4 citations). Through these innovations, Loughney has significantly improved the efficiency, reproducibility, and scalability of analytical methods in the Vaccines Analytical Research and Development department, directly supporting the development of life-saving vaccines.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3